Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Accelerating Therapies for Refractory SJIA Patients
Riskalla, M. M. (PI)
CINCINNATI CHILDREN'S HOSPITAL MED CTR, SYSTEMIC JIA FOUNDATION
10/6/22 → 10/4/25
Project: Research project
-
Adalimumab levels in Induction Control for Chronic Anterior Uveitis
Riskalla, M. M. (PI)
THE CHILDREN'S HOSPITAL OF PHILADELPHIA, CHILDHOOD ARTHRITIS & RHEUM RES ALLIANCE
4/15/22 → 4/14/25
Project: Research project
-
Uveitis Treatment in CARRA II: TNF-inhibitor and beyond
Riskalla, M. M. (PI)
CHILDHOOD ARTHRITIS & RHEUM RES ALLIANCE
9/1/19 → 8/31/20
Project: Research project
-
Procalcitonin and Calprotectin for Differentiation of Infection and Disease Flare in sJIA
Riskalla, M. M. (PI) & Vehe, R. K. (Prior Principal Investigator)
MOUNT SINAI SCHOOL OF MEDICINE, CHILDHOOD ARTHRITIS & RHEUM RES ALLIANCE
4/1/19 → 9/30/22
Project: Research project
-
Effect of an Electronic Pill Bottle on Hydroxychloroquine Adherence in Pediatric Lupus: Results of a Novel Direct-to-Family Pilot Trial
with the CARRA Registry investigators, Jan 2025, In: ACR Open Rheumatology. 7, 1, e11780.Research output: Contribution to journal › Article › peer-review
Open Access -
Emapalumab Treatment in Patients With Rheumatologic Disease–Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study
the REAL-HLH investigators, Feb 2025, In: Arthritis and Rheumatology. 77, 2, p. 226-238 13 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Emapalumab treatment in rheumatologic disease-associated hemophagocytic lymphohistiocytosis: a plain language summary
on behalf of the REAL-HLH Investigators, 2025, In: Immunotherapy. 17, 7, p. 461-478 18 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study
The CARRA Registry Investigators, Jan 2025, In: Arthritis Care and Research. 77, 1, p. 38-49 12 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors
Riskalla, M. M., Barbar-Smiley, F. A., Marka, N. A. & Lerman, M. A., May 2025, In: Clinical and Experimental Rheumatology. 43, 5, p. 946-952 7 p.Research output: Contribution to journal › Article › peer-review
Open Access